Study Group: Protonix Prescribers(?)
Council Members in this Study Group: 17
Request a survey with this Study Group
Leading Experts in this Study Group
Carlos Dujovne, MD
Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC
Carlos Dujovne, MD, is an Internist, Gastroenterologist, Clinical Pharmacologist, Certified Clinical Lipidologist, Fr. Prof. of Medicine and Pharmacology, and Director of Clinical Pharmacology's Lipid-Arteriosclerosis Prevention-Treatment Clinic in Dept. of Medicine and Pharmacology at University of...
Michael BlumeGastroenterologist
Metropolitan Medical Associates
Michael Blume, MD, is a Gastroenterologist at the Metropolitan Medical Associates in Baltimore, Maryland. In addition to being in full-time private practice, he has extensive experience in utilization management and quality improvement. Dr. Blume has done consulting work for various clinical efficiency...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Physicians who Treat GERD (US) | 359 |
| Gastroenterologists who Treat GERD | 367 |
| Gastroenterologists (US) | 820 |
| Physicians who Treat Ulcerative Colitis (US) | 71 |
| IBD Gastroenterologists (US) | 167 |
| IBD Gastroenterologists | 303 |
| Gastroenterologists in Private Practice (US) | 196 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Crestor's results in the Jupiter Study likely to change medical-economic perspectives in statin choices.
1:Crestor is the most potent statin in the market,yet is 3d in sales behind Zocor and Lipitor.2:The efficacy supriority together with its capacity to lower CRP levels led to the highest rate of ASCVD prevention in the shortest period of time evr documented in statin trials.3:The trial in near 18,000...
Mutiple causes for no publications of many reports on FDA approved drugs.Some problems and solutions.
This article is not news for clinical researchers like myself that have performed hundreds of clinical trials in collaboration with the Pharmaceutical Industry. Some of the most common reasons for that are: A)Negative studies are difficult to get published.B)Negative results for the dug of the...
Exenatide may provide practical and cost convenient efficacy in tratment of Metabolic Syndrome patients
More than 50% of patients have the 3 ccomponents to qualify for diagnosis of Metabolic Syndrome.Twwo of the components,Diabetes and Obesity are present in 20-25% of them and are difficult to control.Exenatide seems to provide that benefit.
This potential issue has been of concern since we changed to Propofol based anesthesia for all of our patients approximately five years ago. We made this decision because it made endoscopic procedures significantly more tolerable (essentially painless, except for the bowel prep) for just...
1:Most of our legislators are forcefully endorsing generic drug usage and importing cheaper drugs.2:As a physician specialist in Clinical Pharmacologist I am fully aware or the safety and efficacy pitfalls of poorly manufactured drugs and have done clinical research documenting the risks of patients...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Government/Military Hospital or Clinic
- Consultancy, Healthcare-Focused
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Physician - Division Head
- Physician - Fellow
- Consultant
- Partner